Topics will include the effects of near-infrared light on mitochondrial signaling, photomodulation of acute inflammation, transcranial light penetration in human cadaver brains, photomodulation of stem cells, and light treatment of central nervous system injuries and neuropathic pain.
Particular attention will be paid to the applications of photobiomodulation in dermatology, neurology (including traumatic brain injury and pain reduction), wound healing, kidney disease, and lung function.
“A common thread throughout the photobiomodulation sessions is the effectiveness of light as a noninvasive treatment that alters inflammatory responses, accelerates healing, and does not have the negative side effects normally associated with pharmacological agents,” says Juanita J. Anders, PhD, a professor of anatomy, physiology, and genetics and professor of neuroscience at uniformed services University of the Health Sciences in Bethesda, MD, in a news release.
In the future, many of these medical applications of photobiomodulation may be performed with inexpensive home-use devices. In addition, light therapy could be used as an adjunctive treatment to other therapies, such as pharmaceuticals, with synergistic effect.
For more information on the ASLMS meeting, click here.